|
|
Volumn 24, Issue SUPPL. 16, 1997, Pages 235-236
|
|
Staphylococcus aureus in cystic fibrosis
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIBIOTIC AGENT;
CEFALEXIN;
STAPHYLOCOCCUS VACCINE;
ANTIINFECTIVE AGENT;
ANTIBIOTIC THERAPY;
CONFERENCE PAPER;
CYSTIC FIBROSIS;
HUMAN;
ORAL DRUG ADMINISTRATION;
PRIORITY JOURNAL;
PROGNOSIS;
RESPIRATORY TRACT INFECTION;
STAPHYLOCOCCUS AUREUS;
STAPHYLOCOCCUS INFECTION;
VACCINATION;
ARTICLE;
INCIDENCE;
INFANT;
ISOLATION AND PURIFICATION;
NEWBORN;
PATHOGENICITY;
RISK FACTOR;
TREATMENT OUTCOME;
ANTI-BACTERIAL AGENTS;
CYSTIC FIBROSIS;
HUMANS;
INCIDENCE;
INFANT;
INFANT, NEWBORN;
RISK FACTORS;
STAPHYLOCOCCAL INFECTIONS;
STAPHYLOCOCCUS AUREUS;
TREATMENT OUTCOME;
|
|
EID: 0031302868
PISSN: 87556863
EISSN: None
Source Type: Journal
DOI: 10.1002/ppul.19502308122 Document Type: Conference Paper |
|
Times cited : (7)
|
|
References (0)
|
